Evidence map›Paper›PMID 26621475›Full record

ArticleJournal of biomolecular structure & dynamics2016

Acetoacetate promotes the formation of fluorescent advanced glycation end products (AGEs).

Mousa Bohlooli, Mansour Ghaffari-Moghaddam, Mostafa Khajeh, Zohre Aghashiri, Nader Sheibani, Ali Akbar Moosavi-Movahedi

Abstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Acetoacetate enhancement of glucose mediated DNA glycation.Biochemistry and biophysics reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mousa Bohloolia Department of Biology , University of Zabol , Zabol , Iran.
Mansour Ghaffari-Moghaddamb Department of Chemistry , University of Zabol , Zabol , Iran.
Mostafa Khajehb Department of Chemistry , University of Zabol , Zabol , Iran.
Zohre Aghashirib Department of Chemistry , University of Zabol , Zabol , Iran.
Nader Sheibanic Departments of Ophthalmology and Visual Sciences and McPherson Eye Research Institute , University of Wisconsin School of Medicine and Public Health , Madison , WI , USA.
Ali Akbar Moosavi-Movahedid Institute of Biochemistry and Biophysics, University of Tehran , Tehran , Iran.
Zabol University · IRSmith-Kettlewell Eye Research Institute · USUniversity of Tehran · IR

Funding

Novel Antiangiogenic Peptides for Treatment of Exudative AMDR24EY022883 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2013 to 2017
$6.2M
NEI NIH HHS R24 EY022883
6 · The paper itself

Abstract

Acetoacetate (AA) is an important ketone body, which produces reactive oxygen species (ROS). Advanced glycation end products (AGEs) are defined as final products of glycation process whose production is influenced by the levels of ROS. The accumulation of AGEs in the body contributes to pathogenesis of many diseases including complications of diabetes, and Alzheimer's and Parkinson's disease. Here, we evaluated the impact of AA on production of AGEs upon incubation of human serum albumin (HSA) with glucose. The effect of AA on the AGEs formation of HSA was studied under physiological conditions after incubation with glucose for 35 days. The physical techniques including circular dichroism (CD) and fluorescence spectroscopy were used to assess the impact of AA on formation and structural changes of glycated HSA (GHSA). Our results indicated that the secondary and tertiary structural changes of GHSA were increased in the presence of AA. The fluorescence intensity measurements of AGEs also showed an increase in AGEs formation. Acetoacetate has an activator effect in formation of AGEs through ROS production. The presence of AA may result in enhanced glycation in the presence of glucose and severity of complications associated with accumulation of AGEs.

Indexed as

AcetoacetatesCircular DichroismFluorescenceGlycation End Products, AdvancedKetone BodiesLysineReactive Oxygen SpeciesSpectrometry, FluorescenceSulfhydryl CompoundsAcetoacetatesGlycation End Products, AdvancedKetone BodiesLysineReactive Oxygen SpeciesSulfhydryl Compoundsacetoacetateadvanced glycation end products (AGEs)glycated HSAprolonged incubationreactive oxygen species (ROS), Ketone body

Identifiers

PMID26621475
PMCPMC5223773
OpenAlexW2316956601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.